The first one released was Semaglutide (Ozempic), and diabetics lost weight during clinical studies, explaining why this drug was immediately re-purposed
Experiments conducted on PTC cell lines (GLAG-66 and TPC-1) demonstrated that silencing the DPP-IV gene using siRNA or employing the DPP-IV inhibitor, sitagliptin, resulted in a substantial reduction in the expression of key factors related to PTC pathogenesis
These are research-framed observations, not promises of personal results
Apo E2/2, although rare, is associated with hypercholesterolemia but E4/4 with hypertriglyceridemia [96]
This weight loss can translate into better overall health lowering blood pressure, improving mobility, and reducing the risk of weight-related illnesses
It is an overall great addition to your skincare routine especially if you are struggling with small patches of pigment